Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
G Ital Med Lav Ergon ; 34(3 Suppl): 728-32, 2012.
Article in Italian | MEDLINE | ID: mdl-23405763

ABSTRACT

This paper considers parents empoyment laws in Italy, starting with the very first one in 1902. The legislative development is comparised with Italian history in twentieth and twenty-first centuries, with a particular attention to the Mussolinian age (1922-1943), the Constitution and 1975 Family Law. Social environment is also analyzed in this complex situation.


Subject(s)
Parents , Social Welfare , Work , History, 19th Century , History, 20th Century , Humans , Italy , Social Welfare/history , Social Welfare/legislation & jurisprudence
2.
G Ital Med Lav Ergon ; 32(4): 419-21, 2010.
Article in Italian | MEDLINE | ID: mdl-21086694

ABSTRACT

The Istituto Nazionale della Previdenza Sociale (Inps) is one of the biggest Public Sector organizations in Italy; about 30.000 people work in his structures. Fifteen years ago, Inps launched a long term project with the objective to create a complex and efficient safety and health at work organization. Italian law contemplates a specific kind of physician working on safety and health at work, called "Medico competente", and 85 Inps's physicians work also as "Medico competente". This work describes how IT improved coordination and efficiency in this occupational health's management system.


Subject(s)
Occupational Health , Occupational Medicine , Safety Management , Italy , Public Sector
3.
G Ital Med Lav Ergon ; 32(4 Suppl): 251-4, 2010.
Article in Italian | MEDLINE | ID: mdl-21438274

ABSTRACT

Radon is a chemical radioactive element. It occurs naturally as the decay product of radium; it's responsible for the majority of the mean public exposure to ionizing radiation. It is often the single largest contributor to an individual's background radiation dose, and is the most variable from location to location. Radon gas from natural sources can accumulate in buildings, especially in confined areas such as attics, and basements. Breathing in radon is a cause of lung cancer. In Italy, high levels of radon should be found in underground spaces such as wineries, historical buildings, hot springs or mushrooms farms, and it's a hazard all this workplaces. To ensure the health and safety of employees and others who have access to their work environment, the occupational physician can program inexpensive surveys (with dosemeters) and develop an information plan.


Subject(s)
Air Pollution, Indoor , Occupational Exposure , Radon , Air Pollution, Indoor/analysis , Humans , Occupational Exposure/analysis , Radon/analysis , Workplace
4.
Med Lav ; 99 Suppl 1: 57-66, 2008.
Article in Italian | MEDLINE | ID: mdl-18404899

ABSTRACT

BACKGROUND: According to Italian law, workers are insured against disability through the National Social Security Institute (INPS), whose records contain information on diseases causing disability and occupational histories. OBJECTIVES: Using the INPS data, our objective was to identify any excess risk of disabling diseases in relation to the occupational categories. METHODS: Insurance covers all private sector employees, a small proportion of public sector employees, agricultural labourers, domestic workers, self-employed workers (craftsmen, commercial dealers,farmers), and few other occupational categories. For each insured worker, a database was created containing registry data, occupational history and, for compensated workers, the disease code, for each year from 1994 to 2002. A cohort study design was adopted, in which references were self-employed workers (with mixed exposure) to whom different categories of employees in agriculture, industry, crafts, and services were compared. Data were analyzed by means of Poisson regression, estimating the Incidence Rate Ratio (IRR) and confidence interval (CI) at 99.99%, instead of 95%, in order to set the threshold of error for the entire study at 0.05. RESULTS: In the construction industry there were significantly high risks of disability in both industry and crafts for tumours (industry: IRR = 2.07; IC = 1. 67-2.57; crafts: 2.57; 1.89-3.18), circulatory disorders (industry: IRR = 2.24; IC = 1.65-3.04; crafts.: 3.06; 2.16-4.32), and bone and joint diseases (industry. IRR = 5.0; IC = 3.15-7.94; crafts: 6.58; 5.04-8.59). CONCLUSIONS: The advantage of this approach is to recruit a large number of subjects at limited cost. The procedure here proposed is a mainly exploratory approach aimed at establishing new study hypotheses: disability, in fact, is acknowledged by INPS when its cause is not occupational according to the current literature.


Subject(s)
Occupational Diseases/epidemiology , Occupations/classification , Population Surveillance/methods , Social Security/statistics & numerical data , Workers' Compensation/statistics & numerical data , Adult , Aged , Diagnosis-Related Groups , Disability Evaluation , Female , Humans , Italy/epidemiology , Male , Medical Records/statistics & numerical data , Middle Aged , Occupational Diseases/economics , Occupations/statistics & numerical data , Risk , Social Security/legislation & jurisprudence , Workers' Compensation/legislation & jurisprudence
5.
Med Lav ; 99 Suppl 1: 67-75, 2008.
Article in Italian | MEDLINE | ID: mdl-18404900

ABSTRACT

BACKGROUND: A decreasing time trend for occupational injuries and sickness absence would be the effect of the new legislation (D.Lgs. 626/94 and successive laws) on prevention in occupational settings. Conversely, the reduction of INPS disability would reflect a health improvement due to non-occupational causes. OBJECTIVES: The aim of the study was to investigate the efficacy of the new legislation among employees in industry (where the law was mainly applied), via the time trend of three standardized rates in the Veneto Region. METHODS: The numerator for the rate of occupational accidents (cases occurring in industry workers in the Veneto Region, broken down for sex, age and calendar years) was supplied by INAIL. The denominator for the above rate, as well as numerators and denominators for disability and sickness absence were supplied by INPS. Data were available from 1994 to 2002 for accidents and disability, and from 1997 to 2002 for sickness absence. In every year from 1994 to 2002, the rates were standardized for age and sex with the direct method, using an internal "standard" population. The time trend of year-specific standardized rates was analyzed by Joinpoint regression software. RESULTS: Among industrial workers in the Veneto Region, occupational accidents increased by 0.4% yearly, while disability decreased by 2.56% from 1994 to 2002. Sick absence increased up to 1999, then decreased. CONCLUSIONS: This epidemiological pattern is difficult to explain. The increase in accidents could be due to the increase of non-European Union workers and/or to the fact that accidents on the way to or from work were recognized as occupational accidents by INAIL starting from 2000. Both these phenomena could have contributed to increase the rate that was otherwise diminishing. On the other hand, this same situation could be due to insufficient efficacy of the legislation (D.Lgs. 626/94 and successive laws) for preventing occupational accidents and diseases.


Subject(s)
Occupational Health/statistics & numerical data , Absenteeism , Accidents, Occupational/statistics & numerical data , Accidents, Occupational/trends , Adult , Age Distribution , Aged , Databases, Factual/statistics & numerical data , Female , Humans , Incidence , Italy/epidemiology , Male , Middle Aged , Occupational Health/legislation & jurisprudence , Social Security/legislation & jurisprudence , Social Security/statistics & numerical data , Travel , Workers' Compensation/legislation & jurisprudence , Workers' Compensation/organization & administration , Workers' Compensation/statistics & numerical data
6.
Curr Med Res Opin ; 22(9): 1703-13, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16968574

ABSTRACT

OBJECTIVES: To evaluate the efficacy and safety of trazodone prolonged-release compared with sertraline in the treatment of patients with major depression. RESEARCH DESIGN AND METHODS: A total of 122 patients aged 19-64 years were enrolled in this multicenter, double-blind, double-dummy, randomized, comparator-controlled study. Patients received 7 days of single-blind placebo treatment followed by 6 weeks of double-blind treatment with trazodone prolonged-release 150-450 mg/day (n = 62) or sertraline 50-100 mg/day (n = 60). OUTCOME MEASURES: Efficacy was evaluated by mean changes from baseline in the Hamilton Depression Rating scale (HAM-D), Montgomery Asberg Depression Rating Scale, Hamilton Anxiety Rating scale, and the Clinical Global Impression-Global Improvement/Severity scores; and by the rates of patients responding to treatment and considered to be in remission. Time to onset of efficacy and safety were assessed. RESULTS: Trazodone and sertraline were equally effective in reducing depressive symptoms and promoting remission, and had similar onset times. In the Intent-to-Treat population, there were no significant differences in favor of trazodone at study endpoint in all efficacy measures, while a statistically significant difference was detected in the Per-Protocol population on HAM-D and in the percentage of responders. Analysis of HAM-D factors (anxiety/somatization, cognitive disturbance, retardation, and sleep disturbance) indicated that sleep disturbances were significantly less evident for patients taking trazodone at study endpoint. Adverse drug reactions, mostly of mild intensity, were reported in 42% of trazodone-treated patients (mainly of the nervous system) and 43% of sertraline-treated patients (mainly gastrointestinal). One event was considered to be serious: a patient treated with trazodone 450 mg/day showed moderate anxiety/tremor/insomnia and was hospitalized. Treatment was discontinued; the patient made a full recovery. CONCLUSIONS: This study showed that after 6 weeks, trazodone and sertraline were not different in reducing symptoms of depression and in producing disease remission. Tolerability profiles reflected the differing pharmacological properties of these antidepressants. Trazodone may be a therapeutic option in the treatment of patients with major depression showing prevalent sleep disturbances.


Subject(s)
Antidepressive Agents/administration & dosage , Depressive Disorder, Major/drug therapy , Sertraline/administration & dosage , Trazodone/administration & dosage , Adult , Antidepressive Agents/adverse effects , Antidepressive Agents, Second-Generation/administration & dosage , Antidepressive Agents, Second-Generation/adverse effects , Delayed-Action Preparations , Double-Blind Method , Female , Humans , Male , Middle Aged , Sertraline/adverse effects , Trazodone/adverse effects
7.
Curr Med Res Opin ; 21(8): 1139-46, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16083521

ABSTRACT

OBJECTIVES: To evaluate the efficacy and safety of trazodone prolonged release compared with paroxetine in the treatment of patients with major depression. RESEARCH DESIGN AND METHODS: A total of 108 patients aged 20-68 years were enrolled in this multicentre, double-blind, double-dummy, randomised, paroxetine-controlled study. Each patient received 3 days single-blind placebo treatment followed by 6 weeks double-blind treatment with either trazodone prolonged release 150-450 mg/day (n = 55) or paroxetine 20-40 mg/day (n = 53). OUTCOME MEASURES: Efficacy was evaluated by the rate of patients responding to each treatment and considered to be in remission, and by mean changes from baseline in the Hamilton Depression Rating scale scores (HAM-D), Montgomery Asberg Depression Rating Scale scores (MADRS), and Clinical Global Impression (CGI)--Severity and Global Improvement scores. Time to onset of efficacy and safety were assessed. RESULTS: Trazodone and paroxetine were equally effective at reducing symptoms of depression and promoting remission. Onset of efficacy was slightly faster for patients treated with paroxetine. Overall, there were no significant differences between the groups at endpoint in efficacy measures, and in percentage of responders (> 85%) or patients in remission (> 65%). Sleep disorders (HAM-D subset) were significantly less evident for patients in the trazodone group at the end of the study (p < 0.05). Adverse drug reactions were reported by 35% of trazodone-treated patients (mainly of the nervous system) and 26% of paroxetine-treated patients (mainly gastrointestinal), although none was considered to be serious. CONCLUSIONS: This study showed that after a 6-week period trazodone and paroxetine are not different in reducing the symptoms of depression and, in many patients, in producing the remission of the illness. The known divergence in tolerability profile of the two medications, related to their differing pharmacological properties, was also confirmed. Trazodone may be of advantage in depressed patients with sleep difficulties.


Subject(s)
Depressive Disorder, Major/drug therapy , Paroxetine/therapeutic use , Selective Serotonin Reuptake Inhibitors/therapeutic use , Trazodone/therapeutic use , Adult , Aged , Delayed-Action Preparations , Depressive Disorder, Major/physiopathology , Double-Blind Method , Female , Humans , Male , Middle Aged , Paroxetine/administration & dosage , Paroxetine/adverse effects , Selective Serotonin Reuptake Inhibitors/administration & dosage , Selective Serotonin Reuptake Inhibitors/adverse effects , Trazodone/administration & dosage , Trazodone/adverse effects , Treatment Outcome , White People
8.
Med Lav ; 96 Suppl 2: 5-26, 2005.
Article in Italian | MEDLINE | ID: mdl-16454479

ABSTRACT

BACKGROUND AND OBJECTIVE: In a preliminary consensus document the authors proposed criteria and methods to identify upper limb work-related MSDs due to biomechanical overload. With this document they intend to define severity according to shared models and procedures so as to fit behaviours to diagnostic procedures and their medical-legal assessment. This becomes especially important in view of Ministerial Decree of April 27 2004 fixing the new lists of diseases having a possible work-related origin that must be reported by law in accordance with art. 139 of law n. 1124, and also on account of the impact of such diseases which, for the first time in Italy, are regulated by law. CONTENTS: The working group, which included INAIL and ISPESL experts and was fully supported by SIMFER (Italian Society of Physical Medicine and Rehabilitation) and SINC (Italian Society of Clinical Neurophysiology), defined a general clinical procedure (anamnesis, objective examination and instrumental assessment) regarding each portion of the concerned upper limb (shoulder, elbow and wrist/hand). Once the presence and characteristics of anatomic and functional damages are established, the results allow a classification scheme to be proposed of upper limb diseases (tendon disorders and entrapment neuropathy) divided into 6 increasing severity stages: initial, medium, medium-severe, severe and extremely severe. Special attention was paid to two instrumental examinations that proved to be of great clinical interest, at least in occupational health: echography of soft tissues (in appendix) and electroneurography for entrapment neuropathy. The limitations of this proposal are discussed but the main goal was achieved: to standardize terms and provide homogeneous criteria to achieve classification of upper limb damage due to biomechanical overload for increasing severity levels. The working group research activity is part of a research project funded by ISPESL.


Subject(s)
Cumulative Trauma Disorders/classification , Musculoskeletal Diseases/classification , Occupational Diseases/classification , Occupational Health/legislation & jurisprudence , Upper Extremity , Biomechanical Phenomena , Cumulative Trauma Disorders/diagnosis , Cumulative Trauma Disorders/etiology , Cumulative Trauma Disorders/therapy , Expert Testimony , Humans , Italy , Musculoskeletal Diseases/diagnosis , Musculoskeletal Diseases/etiology , Musculoskeletal Diseases/therapy , Occupational Diseases/diagnosis , Occupational Diseases/etiology , Occupational Diseases/therapy , Occupational Exposure/adverse effects , Occupational Medicine/legislation & jurisprudence , Occupational Medicine/standards , Severity of Illness Index , Societies, Medical , Work Capacity Evaluation
9.
Med Lav ; 94(3): 312-29, 2003.
Article in Italian | MEDLINE | ID: mdl-12918322

ABSTRACT

BACKGROUND AND OBJECTIVES: In via of the progressive emergence in Italy of work-related musculoskeletal disorders, the EPM Research Unit decided to set up a national working group with the aim of producing a Consensus Document including methods and criteria as an initial attempt towards managing such diseases as true "listed" work-related diseases as is already done in the other European Union countries. The working group includes experts from INAIL, ISPESL, welfare assistance institutions, local prevention and health protection services: The group's research activity was included in ISPESL's funded research plan. CONTENTS: The Consensus Document includes a review of epidemiologic issues reported in the international literature, comments on the application of current legislation, observations on the guilt profiles of employers and occupational physicians, as well as medical-legal issues. The document proposes an analytical list of musculoskeletal disorders of upper (and lower) limbs and the operational criteria for identification of working activities involving a risk from upper limb biomechanical overload. In this case, more than on other occasions, it was realized how difficult it is to adopt consolidated task/risk/damage matrices since the same task may or may not be at risk depending both on the way the task is done and on the technical aspects (lines, work parts, procedures, tools) and organization (rate, rotas, breaks). CONCLUSIONS: For the specific aims of the present document, it is possible to identify, though not exhaustively and with some limitations, a series of jobs and working conditions where the risk may be reasonably presumed and for which it is possible to adopt a list system (at least as regards "significant exposure"). The document also includes a chapter on health surveillance recommendations for the occupational physician.


Subject(s)
Musculoskeletal Diseases/epidemiology , Occupational Diseases/epidemiology , Adult , Certification , Cumulative Trauma Disorders/epidemiology , Cumulative Trauma Disorders/prevention & control , European Union , Female , Government Agencies/legislation & jurisprudence , Government Agencies/organization & administration , Humans , Italy/epidemiology , Lower Extremity , Male , Middle Aged , Musculoskeletal Diseases/etiology , Musculoskeletal Diseases/prevention & control , Occupational Diseases/etiology , Occupational Diseases/prevention & control , Occupational Exposure , Occupational Health/legislation & jurisprudence , Occupational Medicine/legislation & jurisprudence , Occupational Medicine/organization & administration , Risk Management , Upper Extremity
SELECTION OF CITATIONS
SEARCH DETAIL
...